Shares of Vernalis plc (LON:VER) hit a new 52-week low during trading on Friday . The stock traded as low as GBX 15 ($0.19) and last traded at GBX 15.25 ($0.20), with a volume of 15,000 shares trading hands. The stock had previously closed at GBX 15.62 ($0.20).

Several analysts recently commented on VER shares. N+1 Singer reissued a “hold” rating and set a GBX 28 ($0.36) price objective on shares of Vernalis plc in a research report on Monday, August 7th. RX Securities reissued a “buy” rating on shares of Vernalis plc in a research report on Monday, August 7th. Stifel Nicolaus cut their price objective on shares of Vernalis plc from GBX 24 ($0.31) to GBX 21 ($0.27) and set a “hold” rating on the stock in a research report on Monday, August 7th. Finally, Panmure Gordon reissued a “hold” rating and set a GBX 31 ($0.40) price objective on shares of Vernalis plc in a research report on Monday, August 7th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of GBX 39.40 ($0.51).

The company’s market cap is GBX 80.27 million. The stock’s 50-day moving average is GBX 16.74 and its 200-day moving average is GBX 19.62.

Vernalis plc (LON:VER) last issued its earnings results on Tuesday, September 12th. The company reported GBX (4.10) (($0.05)) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of GBX (4.50) (($0.06)) by GBX 0.40 ($0.01). The company had revenue of GBX 2,079 million during the quarter. Vernalis plc had a negative return on equity of 22.58% and a negative net margin of 198.87%. On average, equities analysts forecast that Vernalis plc will post ($5.57) earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/09/15/vernalis-plc-ver-sets-new-12-month-low-at-15-00.html.

Vernalis plc Company Profile

Vernalis plc is a commercial-stage pharmaceutical company. The Company is engaged in the research, development and commercialization of pharmaceutical products. The Company operates through two segments: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders.

Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vernalis plc and related companies with MarketBeat.com's FREE daily email newsletter.